Physician profile
Amy Conley
NPI 1871548099
$1,285.33
in general payments reported to CMS, 2019-2025
11 companies · $247 in 2025
The $247 reported for 2025 was more than what 86% of Emergency Medicine providers received nationally (typical 2025 total: $57.10).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $269 · 2022: $168 · 2023: $344 · 2024: $257 · 2025: $247.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $809 · Education: $40.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $808.60 |
| Education | $40.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Csl Behring | $288.35 | 2019-2024 | Kcentra |
| Astrazeneca Pharmaceuticals LP | $157.47 | 2023 | Andexxa |
| Terumo Bct, INC. | $145.44 | 2019 | |
| Abbott Laboratories | $143.09 | 2022 | |
| Abiomed | $125.00 | 2025 | |
| Stryker Corporation | $122.34 | 2025 | Flowsaver |
| Vapotherm INC | $105.89 | 2023 | Vapotherm |
| Inari Medical, INC. | $92.01 | 2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Biosense Webster, INC. | $68.03 | 2023 | Carto 3 |
| Gilead Sciences, INC. | $24.84 | 2022 | |
| Pfizer INC. | $12.87 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amy Conley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.